AI Generated Image
Could Ozempic extend lifespan? Mice lived 100 days longer
New York Post • • health
Key Points:
- A new study found that mice treated with semaglutide, a GLP-1 drug sold as Ozempic and Wegovy, lived about 12% longer than untreated mice, suggesting potential longevity benefits for humans.
- The drug helped reduce key hallmarks of aging, including chronic inflammation and cellular damage, while improving muscle and cognitive function in the treated mice.
- Compared to calorie-restricted mice, those on semaglutide showed similar weight loss and physical improvements but outperformed them in exploratory behavior, memory, and blood sugar regulation.
- Researchers caution that while results are promising, further studies are needed to confirm whether these longevity effects translate to humans.
- Experts highlight the potential for GLP-1 drugs to extend both lifespan and healthspan, possibly offering broad clinical benefits by slowing the aging process linked to chronic diseases.
